About K2bio
K2bio is a Healthcare company based in Houston (United States) founded in 2021 by Andrew Strong. Research site and consulting services are provided as a CRO. K2bio has raised $615.52 thousand across 1 funding round. K2bio offers products and services including CRO Services, Lab Space, Vivarium Services, and Analytical Development. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its legal entity is K2 Biolabs, Inc. Its competitors include Pfizer, LabConnect and Ainos; 2 of its 3 listed competitors have raised funding.
Company details
K2bio was founded in 2021 in Houston, United States. Operations are conducted as a contract research organization in the biotech sector. Research site services and consulting are offered to support client projects. The company is led by co-founder Andrew Strong. Focus is placed on delivering specialized research and advisory functions within the life sciences field.
- Headquarters Houston, United States
- Founders Andrew Strong
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website k2-biolabs.com
- Social LinkedIn
- Legal Name K2 Biolabs, Inc.
- Total Equity Funding$615.52K (USD)
in 1 rounds
- Latest Funding Round$615.52K (USD), Seed
Aug 2023
Products & Services of K2bio
K2bio offers a comprehensive portfolio of products and services, including CRO Services, Lab Space, Vivarium Services, and Analytical Development.
Provides full GLP and non-GLP studies for preclinical development.
Offers ultra-modern bio-accelerator for independent research execution.
Manages on-site vivarium for in vivo studies and client support.
Supports process controls and product assessments per cGMP standards.
Funding Insights of K2bio
K2bio has successfully raised a total of $615.52K through 1 strategic funding round. The most recent funding activity was a Seed round of $615.52 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $615,522
- Total Rounds 1
- Last Round Seed — $615,522
- First Round $615,522
(Aug 2023)
All 1 funding rounds of K2bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $615,522 | Seed | – | – | – |
People of K2bio
1 people are tracked at K2bio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andrew Strong | Co-Founder | Leadership |
Complete people profiles for K2bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of K2bio
2 dated milestones of K2bio across 2 years, from founding to its latest funding, stage changes and deals.
- Founded K2bio is founded.
- Funding First funding round of $616K.
Competitors of K2bio
K2bio has 3 listed competitors in our database, 2 of them funded. They include Pfizer, LabConnect and Ainos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| ainos.com | 1986 | San Diego, United States | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. |
Detailed competitors of K2bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as K2bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about K2bio
K2bio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
K2bio is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
K2bio is a funded company, having raised a total of $615.52K across 1 funding round to date. The company's 1st funding round was a Seed of $615.52K, raised on Aug 2023.
K2bio was founded in 2021 in Houston, United States. Operations are conducted as a contract research organization in the biotech sector. Research site services and consulting are offered to support client projects. The company is led by co-founder Andrew Strong. Focus is placed on delivering specialized research and advisory functions within the life sciences field.
K2bio's top competitors include Pfizer, LabConnect and Ainos.
K2bio offers CRO Services, Lab Space, Vivarium Services, and Analytical Development.
K2bio operates through K2 Biolabs, Inc..